放射治疗与全身疗法的整合在先进的三阴性乳腺癌中
1The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China.
Critical reviews in oncology/hematology
|October 30, 2024
概括
将放射疗法与全身疗法结合在一起,对晚期三阴性乳腺癌 (TNBC) 显示出有前途. 本综述探讨了临床前和临床证据,以改善TNBC患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 医学瘤学 医学瘤学
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有不良预后的侵袭性亚型.
- 针对高级TNBC的全身疗法面临着有效性和副作用的挑战.
- 放射治疗提供了局部控制的好处,特别是在不可手术或转移性疾病.
研究的目的:
- 审查最近在结合放射疗法和系统疗法的进展,用于高级TNBC.
- 综合临床前和临床证据,以结合治疗的有效性和安全性.
- 确定新的治疗策略,并为TNBC管理提供最佳实践信息.
主要方法:
- 临床前研究和临床试验的文献综述.
- 专注于TNBC中放射治疗和全身药物之间的协同作用.
- 综合治疗方法的疗效,安全性和生存数据的分析.
主要成果:
- 联合放射疗法和全身疗法表明,在晚期TNBC中,可能会改善结果.
- 有证据表明,当将局部区域辐射疗法与全身治疗相结合时,存在生存优势.
- 该审查强调了通过多学科方法管理先进的TNBC的有希望的进展.
结论:
- 将放射治疗与全身疗法结合在一起,是高级TNBC的一个有希望的策略.
- 进一步的研究和临床证据对于优化联合治疗方案至关重要.
- 这种方法有可能改善TNBC管理中的生存率和患者结果.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486


